Comments on “Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study”

We read the article entitled “Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study” by Zhang et al [1] with great interest. The findings of the study indicated that adding concurrent chemotherapy to r adiotherapy did not contribute to improved survival rates in patients with stage II and T3N0 nasopharyngeal carcinoma (NPC) with adverse factors. This is a substantial study as it comprehensively evaluates this controversial issue with a large number of patients and propensity score-matching analysi s.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Letter to the Editor Source Type: research